Inactief instrument

Andere talen StemCells Inc Nasdaq

Aandelen

US85857R2040

slotkoers Nasdaq Andere beurzen
- ^USD	-

08/07	Microbot Medical neemt eerste patiënt op in klinisch onderzoek met Liberty Chirurgisch Systeem	MT
08/07	Microbot Medical heeft de eerste patiënt ingeschreven in zijn cruciale klinische studie bij mensen	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial	09/07
Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System	08/07
Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial	08/07
Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial	08/07
Microbot Medical Signs Clinical Trial Deal With Baptist Hospital of Miami	03/07
Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial	03/07
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	20/06
Microbot Medical Inc Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial	20/06
Microbot Medical Inc. announced that it has received $1.762502 million in funding	20/06
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	17/06
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial	17/06
Microbot Medical Files Common Stock Registration Statement	11/06
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	04/06
Sector Update: Health Care Stocks Gain Late Afternoon	03/06
Microbot Gets FDA Nod to Start Trial, to Raise $2.35 Million From Direct Offering Deal; Shares Soar	03/06
Top Midday Gainers	03/06
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	03/06
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial	03/06
Microbot Medical Inc. Has Received FDA Approval to Proceed with Its Pivotal Human Clinical Trial	03/06
Microbot Medical Inc. announced that it expects to receive $1.762502 million in funding	03/06

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen StemCells Inc Nasdaq

Aandelen

US85857R2040

Andere talen

Filters